Great Point Partners’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-25,000
| Closed | -$627K | – | 30 |
|
2024
Q2 | $627K | Sell |
25,000
-951,981
| -97% | -$23.9M | 0.12% | 32 |
|
2024
Q1 | $22M | Hold |
976,981
| – | – | 3.43% | 10 |
|
2023
Q4 | $20.9M | Buy |
976,981
+82,648
| +9% | +$1.77M | 3.57% | 12 |
|
2023
Q3 | $16.1M | Hold |
894,333
| – | – | 2.93% | 14 |
|
2023
Q2 | $18.2M | Buy |
894,333
+90,000
| +11% | +$1.83M | 3.56% | 12 |
|
2023
Q1 | $17.5M | Buy |
804,333
+789,333
| +5,262% | +$17.2M | 3.44% | 13 |
|
2022
Q4 | $465K | Buy |
+15,000
| New | +$465K | 0.09% | 40 |
|
2022
Q3 | – | Sell |
-453,118
| Closed | -$9.2M | – | 42 |
|
2022
Q2 | $9.2M | Sell |
453,118
-246,882
| -35% | -$5.01M | 2.21% | 19 |
|
2022
Q1 | $17.3M | Buy |
700,000
+107,750
| +18% | +$2.67M | 4.19% | 12 |
|
2021
Q4 | $20.6M | Buy |
592,250
+42,705
| +8% | +$1.48M | 4.57% | 5 |
|
2021
Q3 | $14.9M | Buy |
549,545
+149,494
| +37% | +$4.05M | 3.47% | 11 |
|
2021
Q2 | $10.4M | Buy |
+400,051
| New | +$10.4M | 2.18% | 21 |
|